{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:36:03Z","timestamp":1794627363984,"version":"4.9.1"},"reference-count":13,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Fibromyalgia (FM) is a chronic condition characterized by widespread pain and a broad range of associated symptoms. Among these, significant psychiatric comorbidities\u2014particularly anxiety and depression\u2014are frequently observed. This study aimed to evaluate the relationship between the severity of fibromyalgia and symptoms of anxiety and depression. We correlated the scores from the Hospital Anxiety and Depression Scale (HADS) with those from various fibromyalgia symptom questionnaires, including the Widespread Pain Index (WPI), the Symptom Severity Score (SS), and the 12-Item Short Form Survey (SF-12). Methods: A sample of 59 FM patients treated at the Department of Internal Medicine at Cl\u00ednica Universidad de Navarra was assessed using HADS, SS, SF-12, and WPI scales. Spearman correlation analysis was performed to examine the relationships among the scale scores. Results: The analysis revealed a statistically significant moderate correlation (r = 0.442; p &lt; 0.01) between HADS and the Symptom Severity Score, a statistically significant strong negative correlation (r = \u22120.678; p &lt; 0.01) between HADS and the Mental Component Summary (MCS-12), and a statistically significant moderate negative correlation (r = \u22120.417; p &lt; 0.01) between the SS Score and the Physical Component Summary (PCS-12). Conclusions: These findings suggest a clear association between anxiety and depressive symptoms, as measured by HADS, and the severity of fibromyalgia.<\/jats:p>","DOI":"10.3390\/jcm14165867","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T07:50:46Z","timestamp":1755676246000},"page":"5867","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anxiety and Depression Scales in Patients with Fibromyalgia: Correlation with Disease Symptomatology"],"prefix":"10.3390","volume":"14","author":[{"given":"Javier","family":"Amezqueta","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Navarra, 31009 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-7234","authenticated-orcid":false,"given":"Javier Nicol\u00e1s","family":"Garc\u00eda Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinica Universidad de Navarra, University of Navarra, 31009 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.genhosppsych.2011.09.004","article-title":"Psychiatric disorders as assessed with SCID in chronic pain patients: The anxiety disorders precede the onset of pain","volume":"34","author":"Knaster","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","article-title":"Prevalence of fibromyalgia: Literature review update","volume":"57","author":"Marques","year":"2017","journal-title":"Rev. Bras. Reumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5114\/reum\/163094","article-title":"Fibromyalgia\u2014Etiology, diagnosis and treatment including perioperative management in patients with fibromyalgia","volume":"61","author":"Lisowska","year":"2023","journal-title":"Reumatologia"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pagliai, G., Giangrandi, I., Dinu, M., Sofi, F., and Colombini, B. (2020). Nutritional interventions in the management of fibromyalgia syndrome. Nutrients, 12.","DOI":"10.3390\/nu12092525"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ruschak, I., Montes\u00f3-Curto, P., Rossell\u00f3, L., Mart\u00edn, C.A., S\u00e1nchez-Montes\u00f3, L., and Toussaint, L. (2023). Fibromyalgia Syndrome Pain in Men and Women: A Scoping Review. Healthcare, 11.","DOI":"10.3389\/fmed.2024.1286729"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"ref_7","first-page":"CD010585","article-title":"Combination pharmacotherapy for the treatment of fibromyalgia in adults","volume":"2018","author":"Thorpe","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lowry, E., Marley, J., McVeigh, J.G., McSorley, E., Allsopp, P., and Kerr, D. (2020). Dietary interventions in the management of fibromyalgia: A systematic review and best-evidence synthesis. Nutrients, 12.","DOI":"10.3390\/nu12092664"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2212939","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of Amitriptyline and US Food and Drug Administration\u2013Approved Treatments for Fibromyalgia","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_10","first-page":"e17332","article-title":"A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?","volume":"13","author":"Khurshid","year":"2021","journal-title":"Cureus"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5606\/tftrd.2020.3331","article-title":"The relationship between disease severity and defense mechanisms in fibromyalgia syndrome","volume":"66","author":"Berk","year":"2020","journal-title":"Turk. J. Phys. Med. Rehabil."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Schweiger, V., Perini, G., Del Piccolo, L., Perlini, C., Donisi, V., Gottin, L., Martini, A., Donadello, K., Del Balzo, G., and Moro, V. (2022). Bipolar Spectrum Symptoms in Patients with Fibromyalgia: A Dimensional Psychometric Evaluation of 120 Patients. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192416395"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5867\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:31:24Z","timestamp":1760034684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":13,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165867"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165867","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}